HUP9903869A3 - Oral composition comprising a triazole antifungal compound - Google Patents

Oral composition comprising a triazole antifungal compound

Info

Publication number
HUP9903869A3
HUP9903869A3 HU9903869A HUP9903869A HUP9903869A3 HU P9903869 A3 HUP9903869 A3 HU P9903869A3 HU 9903869 A HU9903869 A HU 9903869A HU P9903869 A HUP9903869 A HU P9903869A HU P9903869 A3 HUP9903869 A3 HU P9903869A3
Authority
HU
Hungary
Prior art keywords
oral composition
antifungal compound
triazole antifungal
triazole
compound
Prior art date
Application number
HU9903869A
Other languages
English (en)
Hungarian (hu)
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of HUP9903869A2 publication Critical patent/HUP9903869A2/hu
Publication of HUP9903869A3 publication Critical patent/HUP9903869A3/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/167—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface
    • A61K9/1676—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface having a drug-free core with discrete complete coating layer containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
HU9903869A 1996-06-28 1997-06-25 Oral composition comprising a triazole antifungal compound HUP9903869A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US67243296A 1996-06-28 1996-06-28
PCT/US1997/010122 WO1998000116A1 (en) 1996-06-28 1997-06-25 Oral composition comprising a triazole antifungal compound

Publications (2)

Publication Number Publication Date
HUP9903869A2 HUP9903869A2 (hu) 2000-06-28
HUP9903869A3 true HUP9903869A3 (en) 2000-07-28

Family

ID=24698529

Family Applications (1)

Application Number Title Priority Date Filing Date
HU9903869A HUP9903869A3 (en) 1996-06-28 1997-06-25 Oral composition comprising a triazole antifungal compound

Country Status (16)

Country Link
EP (1) EP0914100A1 (ja)
JP (1) JP2000514059A (ja)
KR (1) KR20000022294A (ja)
CN (1) CN1228693A (ja)
AU (1) AU731704B2 (ja)
BR (1) BR9710069A (ja)
CA (1) CA2258683C (ja)
CZ (1) CZ421498A3 (ja)
HU (1) HUP9903869A3 (ja)
IL (1) IL127780A0 (ja)
NO (1) NO986087L (ja)
NZ (1) NZ333514A (ja)
PL (1) PL330864A1 (ja)
SK (1) SK177598A3 (ja)
TR (1) TR199802718T2 (ja)
WO (1) WO1998000116A1 (ja)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT969821E (pt) * 1997-03-26 2003-10-31 Janssen Pharmaceutica Nv Pastilhas tendo um nucleo revestido com um antifungico e um polimero
CN1272785A (zh) * 1998-06-11 2000-11-08 Em工业股份有限公司 微渗透药物控释系统
BR9906712A (pt) * 1998-07-17 2000-10-10 Janssen Pharmaceutica Nv Péletes que apresentam um núcleo revestido com um antifúngico e um polìmero
ES2157731B1 (es) 1998-07-21 2002-05-01 Liconsa Liberacion Controlada Preparacion farmaceutica oral de un compuesto de actividad antifungica y procedimiento para su preparacion.
US6248363B1 (en) * 1999-11-23 2001-06-19 Lipocine, Inc. Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
FR2795961B1 (fr) * 1999-07-09 2004-05-28 Ethypharm Lab Prod Ethiques Composition pharmaceutique contenant du fenofibrate micronise, un tensioactif et un derive cellulosique liant et procede de preparation
US7863331B2 (en) 1999-07-09 2011-01-04 Ethypharm Pharmaceutical composition containing fenofibrate and method for the preparation thereof
KR100694667B1 (ko) * 1999-12-08 2007-03-14 동아제약주식회사 생체내이용률 향상과 개인간 및 개인내 흡수 편차를감소시킨 이트라코나졸 함유 항진균성 제제
EP1842532A3 (en) * 2001-02-06 2009-04-22 Stiefel Laboratories, Inc. Oral sparingly water-soluble antifungal formulations and methods of making the same
US6663897B2 (en) * 2001-02-06 2003-12-16 Dsm Ip Assets B.V. Oral itraconazole formulations and methods of making the same
FR2842736B1 (fr) 2002-07-26 2005-07-22 Flamel Tech Sa Formulation pharmaceutique orale sous forme d'une pluralite de microcapsules permettant la liberation prolongee de principe(s) actif(s) peu soluble(s)
ITMI20031096A1 (it) * 2003-05-30 2004-11-30 Eurand Spa Microcapsule per coacervazione contenenti farmaco incorporato nel polimero di rivestimento
DE10355461A1 (de) 2003-11-27 2005-06-23 Bayer Healthcare Ag Verfahren zur Herstellung einer festen, oral applizierbaren pharmazeutischen Zusammensetzung
US11304960B2 (en) 2009-01-08 2022-04-19 Chandrashekar Giliyar Steroidal compositions
US20180153904A1 (en) 2010-11-30 2018-06-07 Lipocine Inc. High-strength testosterone undecanoate compositions
US9358241B2 (en) 2010-11-30 2016-06-07 Lipocine Inc. High-strength testosterone undecanoate compositions
US9034858B2 (en) 2010-11-30 2015-05-19 Lipocine Inc. High-strength testosterone undecanoate compositions
US20120148675A1 (en) 2010-12-10 2012-06-14 Basawaraj Chickmath Testosterone undecanoate compositions
WO2016033549A2 (en) 2014-08-28 2016-03-03 Lipocine Inc. (17-ß)-3-OXOANDROST-4-EN-17-YL TRIDECANOATE COMPOSITIONS AND METHODS OF THEIR PREPARATION AND USE
WO2016033556A1 (en) 2014-08-28 2016-03-03 Lipocine Inc. BIOAVAILABLE SOLID STATE (17-β)-HYDROXY-4-ANDROSTEN-3-ONE ESTERS
CN105949278B (zh) * 2016-03-30 2019-12-06 南京曼杰生物科技有限公司 一种取代的四氢呋喃水溶性衍生物及其应用
US11559530B2 (en) 2016-11-28 2023-01-24 Lipocine Inc. Oral testosterone undecanoate therapy

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5580578A (en) * 1992-01-27 1996-12-03 Euro-Celtique, S.A. Controlled release formulations coated with aqueous dispersions of acrylic polymers
PH30929A (en) * 1992-09-03 1997-12-23 Janssen Pharmaceutica Nv Beads having a core coated with an antifungal and a polymer.
SK283035B6 (sk) * 1993-12-21 2003-02-04 Schering Corporation Tetrahydrofuránová zlúčenina, spôsob jej prípravy, jej farmaceuticky prijateľný ester, soľ a farmaceutický prostriedok

Also Published As

Publication number Publication date
CN1228693A (zh) 1999-09-15
BR9710069A (pt) 1999-08-10
CA2258683C (en) 2007-07-31
CA2258683A1 (en) 1998-01-08
CZ421498A3 (cs) 1999-06-16
SK177598A3 (en) 1999-07-12
PL330864A1 (en) 1999-06-07
IL127780A0 (en) 1999-10-28
EP0914100A1 (en) 1999-05-12
AU3387497A (en) 1998-01-21
AU731704B2 (en) 2001-04-05
TR199802718T2 (xx) 1999-03-22
JP2000514059A (ja) 2000-10-24
WO1998000116A1 (en) 1998-01-08
NZ333514A (en) 2000-05-26
KR20000022294A (ko) 2000-04-25
NO986087D0 (no) 1998-12-23
HUP9903869A2 (hu) 2000-06-28
NO986087L (no) 1999-02-26

Similar Documents

Publication Publication Date Title
HUP9903869A3 (en) Oral composition comprising a triazole antifungal compound
EG24414A (en) A novel compound form
HUP9901620A3 (en) Antifungal compositions containing itraconazole
AU4428397A (en) Oral compositions containing a zinc compound
ZA9510223B (en) Fungicidal compounds
ZA961522B (en) Fungicidal composition
IL129940A (en) Compositions containing an antifungal compound and a phospholipid
IL125281A0 (en) Novel fungicidal composition comprising a 2-imidazolin-5-one
ZA953954B (en) A mineral-fiber composition
HUP9903388A3 (en) Fungicidal composition
IL123715A0 (en) Antifungal compositions
AU7937998A (en) Antifungal triazole compounds
HU9600085D0 (en) A mineral-fiber composition
ZA9410267B (en) Fungicidal composition based on iprodione and a triazole compound
NZ320449A (en) Dunnione as a fungicidal composition
GB2299509B (en) Fungicidal composition based on prochloraz and on a triazole compound
IL116958A0 (en) Fungicidal compositions
GB2308301B (en) New fungicidal compositions
ZA954853B (en) A mineral-fibre composition
AP9901498A0 (en) Novel fungicidal composition comprising a 2-imidazolin-5-one
GB9619534D0 (en) Fungicidal composition
GB9610960D0 (en) A compound
GB9605725D0 (en) A compound
GB9611006D0 (en) Antifungal compositions
SI0710220T1 (en) A mineral-fiber composition